#insulet-corporation

[ follow ]
#eli-lilly
Business
from24/7 Wall St.
6 days ago

Eli Lilly's Path to $1 Trillion Runs Directly Through the AI Boom

Eli Lilly's GLP-1 franchises dominate the weight-loss market, projecting significant revenue growth and a potential market cap exceeding $1 trillion.
Business
from24/7 Wall St.
6 days ago

Eli Lilly's Path to $1 Trillion Runs Directly Through the AI Boom

Eli Lilly's GLP-1 franchises dominate the weight-loss market, projecting significant revenue growth and a potential market cap exceeding $1 trillion.
Public health
fromBusiness Matters
3 days ago

Life Imaging Reviews: What 100,000 Screenings Taught One Founder About Early Detection

Early detection of heart disease and cancer significantly impacts survival rates, emphasizing the need for preventive screening across different regions.
Wearables
fromThe Verge
4 days ago

A year of continuous glucose monitoring pushed me to the edge

Glucose tracking is increasingly popular among non-diabetics, with many using continuous glucose monitors for health insights.
fromWIRED
3 days ago

This AI Button Wearable From Ex-Apple Engineers Looks Like an iPod Shuffle

Unlike the Humane Ai pin, which got lots of criticism for taking a painfully long time to reply to queries, the Button is designed to be nearly instantaneous.
Apple
Medicine
fromTNW | Opinion
1 day ago

AI health tech is booming. The cures are not.

AI in drug discovery shows promise but has not yet delivered significant breakthroughs for patients.
Wearables
fromThe Verge
2 days ago

Why your Whoop might tell you to up your testosterone

Whoop and Oura are leading health tech innovations, but rapid advancements can lead to unexpected consequences.
fromwww.gsmarena.com
1 week ago

Google teases its Whoop competitor

Google's new health tracker, teased by Steph Curry, features a Whoop-inspired design and will include a subscription service with an AI-based personal health coach.
Mobile UX
NYC startup
fromFast Company
1 week ago

Wegovy's new pricing could save you $1,200-but it's not for everyone

Novo Nordisk launched a subscription program for Wegovy to reduce cost uncertainty and improve access to obesity treatment.
Data science
fromTechCrunch
1 week ago

Mantis Biotech is making 'digital twins' of humans to help solve medicine's data availability problem | TechCrunch

Large language models can enhance genomics and clinical practices, but struggle with rare diseases due to data scarcity.
from24/7 Wall St.
2 days ago

Who Benefits From Amazon Pharmacy Stocking Eli Lilly's New Weight Loss Pill

Amazon Pharmacy's decision to stock Foundayo at One Medical kiosks represents a significant shift in how Americans can access weight-loss medications, with plans for same-day home delivery.
Medicine
from24/7 Wall St.
2 weeks ago

Wave Life Sciences Slips as Obesity Data Fails to Convince

The INLIGHT interim readout reported a 14.3% placebo-adjusted reduction in visceral fat six months after a single dose, alongside preservation of lean muscle mass - a differentiated profile compared to GLP-1 therapies that often reduce muscle alongside fat.
Cancer
Medicine
fromwww.bbc.com
4 days ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
#glp-1
Medicine
from24/7 Wall St.
1 week ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
Medicine
from24/7 Wall St.
1 week ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
Wearables
fromThe Verge
1 week ago

How the Apple Watch defined modern health tech

The Apple Watch Series 4 revolutionized health tech with FDA-cleared atrial fibrillation detection, influencing the development of advanced consumer health wearables.
Health
fromThe Verge
3 weeks ago

Fitbit's AI health coach will soon be able to read your medical records

Google enables Fitbit users to link medical records to their AI health coach for more personalized wellness advice, following similar moves by Amazon, OpenAI, and Microsoft.
#glp-1-medications
Medicine
fromPsychology Today
6 days ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
SF food
fromFast Company
1 month ago

This grocery chain is offering free GLP-1 starter kits

ShopRite launched free 'Wellness Your Way' starter kits for first-time GLP-1 prescription customers to capture increased food spending from this growing demographic.
Medicine
fromScienceDaily
3 weeks ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Medicine
fromPsychology Today
6 days ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
SF food
fromFast Company
1 month ago

This grocery chain is offering free GLP-1 starter kits

ShopRite launched free 'Wellness Your Way' starter kits for first-time GLP-1 prescription customers to capture increased food spending from this growing demographic.
Medicine
fromScienceDaily
3 weeks ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Apple
fromTechRepublic
2 weeks ago

Perplexity Health Connects Medical Records and Wearables in New AI Push - TechRepublic

Perplexity Health consolidates health data from various sources into a single dashboard for personalized health insights.
Medicine
fromThe New Yorker
6 days ago

Why Are People Injecting Themselves with Peptides?

Health and wellness influencers promote unapproved peptide treatments, raising concerns about consumer safety and the future of FDA regulations.
Wearables
fromZDNET
1 week ago

Galaxy Watch users in the US can finally track their blood pressure - here's what you need

Samsung Galaxy Watch users in the US can now monitor blood pressure with calibration required using an inflatable cuff monitor.
Health
fromNature
3 weeks ago

Insulin resistance prediction from wearables and routine blood biomarkers - Nature

Diabetes affects 537 million adults globally with type 2 diabetes comprising 90% of cases, driven by lifestyle factors and characterized by insulin resistance or deficiency leading to long-term organ damage.
Healthcare
fromEngadget
1 month ago

Microsoft's Copilot Health can use AI to turn your fitness data and medical records 'into a coherent story'

Microsoft's Copilot Health aggregates medical records, fitness data, and health history to help patients prepare informed questions for their doctors, while explicitly not replacing professional medical advice.
Wearables
fromGSMArena.com
1 week ago

Your Samsung Galaxy Watch can now measure your blood pressure in the US

Samsung's Galaxy Watch4 and later models can now measure blood pressure in the US using the Samsung Health Monitor app.
Medicine
fromwww.scientificamerican.com
1 week ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
Health
fromThe Verge
3 weeks ago

Misusing my fitness tracker to do less, not more

A person with long COVID, POTS, and mast cell activation syndrome experienced severe crashes from overexertion but learned to manage symptoms through careful activity pacing and lifestyle adjustments over three years.
Medicine
fromWIRED
1 week ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Healthcare
fromFortune
1 month ago

Microsoft launches Copilot Health, a dedicated space for personal health data and AI-driven insights | Fortune

Microsoft launched Copilot Health, an AI assistant feature that integrates and analyzes health data from wearables, electronic health records, and lab results to provide personalized health insights and provider recommendations.
from24/7 Wall St.
1 month ago

X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention

X4 Pharmaceuticals drew a fresh initiation from Guggenheim, which assigned a Buy rating and $12 price target, framing the company as a "differentiated hematology play" with significant upside in the next 18 months. The firm's thesis centers on mavorixafor, a potential first-in-class oral CXCR4 antagonist already approved for WHIM syndrome and currently in Phase 3 development for primary chronic neutropenia.
Cancer
Medicine
fromJezebel
2 weeks ago

First It Was Mini-Livers; Now Science Can Give You a Bonus Pancreas as Well?

New studies show potential for injectable mini-livers and implantable devices with pancreatic cells to aid liver disease and diabetes management.
Miscellaneous
fromBoston.com
1 month ago

Massachusetts joins insurers cutting coverage for popular weight-loss drugs

Massachusetts ended GLP-1 weight loss drug coverage for 460,000 state employees in a 10-7 vote to reduce $46 million in annual costs and control state budget strain.
Business
from24/7 Wall St.
1 month ago

What Smart Money Loves About Lilly

Eli Lilly delivered consecutive blowout quarters with strong revenue and earnings beats, driven by Mounjaro and Zepbound dominance, while institutional investors accumulate shares despite a year-to-date pullback.
Startup companies
fromBoston.com
1 month ago

Two Boston startups join the race to create the next major weight-loss drug

Boston startups Vivtex and Nimbus Therapeutics partner with major pharmaceutical companies to develop next-generation oral obesity treatments using advanced drug delivery and AI technologies.
fromWIRED
1 month ago

Cuffless Blood Pressure Monitoring Is Coming. We Explain What It Is and How to Use It

Since 1990, the incidence of hypertension has increased globally, with up to one in three adults worldwide affected by it. Most of those people have no idea they have it. If people could diagnose and monitor hypertension at home, the World Health Organization estimates that up to 76 million lives could be saved with easy fixes, like stopping smoking or adjusting diet.
Health
Information security
fromSecurityWeek
1 month ago

Medical Device Maker UFP Technologies Hit by Cyberattack

UFP Technologies detected a cybersecurity intrusion on February 14 involving file theft and IT system disruption, with operations continuing despite impacts to billing and delivery label systems.
Medicine
fromNature
3 weeks ago

Data from smart watches reveal early signs of insulin resistance

Wearable device data patterns detect insulin resistance and metabolic dysfunction earlier than clinical tests, enabling earlier intervention.
Medicine
fromNature
3 weeks ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
#glp-1-drugs
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Venture
fromMedCity News
2 months ago

JPM Deals Recap: Boston Scientific Acquisition, a Mega Round for Parabilis, Enodia Emerges & More - MedCity News

Biotech financing activity increased around JPM week, with startup rounds and an IPO signaling renewed momentum despite fewer M&A announcements.
Gadgets
fromThe Verge
1 month ago

'Wellness' feels like it's losing all meaning in health tech

Oura is lobbying for a 'digital health screener' exemption to relax FDA oversight for low-risk wearable health features, highlighting regulatory ambiguity and enforcement challenges.
Public health
fromwww.theguardian.com
2 months ago

Off the Scales by Aimee Donnellan review inside the Ozempic revolution

New weight-loss injectable drugs reshape body norms, offering transformative health benefits while fueling cosmetic use, stigma, and unequal social valuation based on appearance.
fromFast Company
2 months ago

Ozempic just released its own version of the iconic Mac vs. PC ad

The actors are reprising their roles from Apple's Mac vs. PC ads playing the personifications of a name brand and the alternative-but now for weight-loss drugs. Long personified Mac in the original Apple campaign by dressing in a more youthful, casual way than Hodgman, who personified a stuffy, dorky PC by wearing glasses and a suit and tie with a closely cropped haircut. (Think Steve Jobs versus Bill Gates.) In the Apple ads, Mac was always portrayed by Long as more cool and capable.
Marketing
Medicine
fromFortune
1 month ago

Health startup Noom is now adding weight loss injectables to its offerings, says 'outcomes are so much better' | Fortune

Noom launches Noom Med, combining GLP-1 obesity drugs like Wegovy with behavioral coaching for $120 monthly, joining competitors capitalizing on highly effective weight-loss medications.
fromYanko Design - Modern Industrial Design News
1 month ago

Meta Wants to Put an AI Health Tracker on Your Wrist in 2026. What Could Go Wrong?? - Yanko Design

Meta is building a smartwatch, and it wants to know your heart rate, your sleep patterns, your activity levels, and whatever else it can pull from a sensor pressed against your skin all day. The device is codenamed Malibu 2, it's targeting a 2026 launch, and by most accounts it sounds like a perfectly competent health wearable. The problem isn't the hardware. The problem is the company attached to it.
Gadgets
Business
fromFuturism
2 months ago

Novo Nordisk Furious at $49 Knockoff Ozempic Pill

Novo Nordisk is pursuing legal and regulatory action against Hims & Hers over a low-cost compounded Wegovy knockoff, prompting FDA scrutiny and volatile stock moves.
Public health
fromwww.cbc.ca
2 months ago

Parents urge province to create standard of care for Ontario students with diabetes | CBC News

Provincewide, standardized school care for Type 1 diabetic children is needed to ensure consistent safety, trained assistance, and access to glucose sources and insulin management.
Health
fromBusiness Insider
2 months ago

My two weeks in sugar jail

Continuous glucose monitoring reveals blood sugar fluctuations, but limited evidence links stabilizing glucose in healthy people to sustained energy improvement or weight loss.
Wearables
fromWIRED
1 month ago

Aktiia's Cuffless Band Is the Future of Blood Pressure Monitoring

Hilo uses optical sensors to measure blood pressure continuously without inflating a cuff, enabling non-disruptive nighttime monitoring that traditional cuffs cannot provide.
from24/7 Wall St.
1 month ago

Medtronic Just Posted Its Best Quarter in 2.5 Years

Medtronic ( NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026. Cardiac Ablation Drives Outperformance The Cardiovascular Portfolio led the quarter with 13.8% reported growth, powered by an exceptional 80% surge in Cardiac Ablation Solutions. U.S. cardiac ablation revenue exploded 137%, driven by the company's pulsed field ablation (PFA) portfolio. Cardiac Rhythm & Heart Failure revenue reached $1.86 billion, up 17%, while Diabetes posted 8.3% organic growth to $796 million.
Healthcare
fromHarvard Gazette
2 months ago

AI is speeding into healthcare. Who should regulate it? - Harvard Gazette

Whenever medical AI handles anything with medium to high risk, you want regulation: internal self-regulation or external governmental regulation. It's mostly been internal thus far, and there are differences in how each hospital system validates, reviews, and monitors healthcare AI. When done on a hospital-by-hospital basis like this, costs to do this kind of evaluation and monitoring can be significant, which means some hospitals can do this, and some can't.
Public health
#ozempic
fromIndependent
2 months ago
Public health

Revealed: The massive HSE spend on weight-loss jabs like Ozempic - and which area is availing of the drugs most

fromIndependent
2 months ago
Public health

Revealed: The massive HSE spend on weight-loss jabs like Ozempic - and which area is availing of the drugs most

Wearables
fromTechCrunch
1 month ago

Wearable startup CUDIS launches a new health ring line with an AI-fueled 'coach' | TechCrunch

CUDIS launches an AI-powered health ring with an agent coach, gamified points system for healthy behaviors, and Pace of Aging tracking to incentivize and optimize user wellness.
Medicine
fromTheregister
1 month ago

MIT researchers test injectable 'satellite liver' in mice

MIT researchers developed an injectable 'satellite liver' using hepatocytes and hydrogel microspheres that successfully restored liver function in mice for eight weeks without requiring surgery.
Healthcare
fromFast Company
1 month ago

This startup is using AI to cut hospital alarms-and may soon help patients get home faster

CalmWave integrates monitoring data with EMR to reduce ICU alarm fatigue by silencing unnecessary alerts and prioritizing truly urgent alarms.
Healthcare
fromThe Atlantic
2 months ago

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.
fromwww.bbc.com
1 month ago

'I thought I was going to die' - Woman calls for tighter weight-loss jabs checks

Emma Dyer remembers the moment she clicked "buy now" on a set of weightloss jabs she found online. She had no medical consultation, no ID checks, and no questions about her history of anorexia and bulimia. "It was just so easy - too easy," she says. "They never asked for my medical history or what medication I was taking. It was like buying groceries."
Health
Wearables
fromgizmodo.com
2 months ago

Withings U-Scan Review: I Tracked My Urine to Find Out if It's the Next Wellness Tracker

Home urine monitors like Withings U-Scan make urine analysis easy, entertaining, and informative but unnecessary for most healthy people.
Medicine
fromWIRED
1 month ago

AI Digital Twins Are Helping People Manage Diabetes and Obesity

An app predicts individualized blood sugar responses, provides AI-driven daily recommendations and coaching, and supported a user in weight loss and improved biometrics.
Medicine
fromWIRED
2 months ago

Using a Continuous Glucose Monitor Can Help You Decode Your Daily Eating Habits

Consumer continuous glucose monitors enable personal blood-glucose tracking, encouraging diet and exercise changes that help manage blood sugar and support weight and metabolic health.
Medicine
fromEntrepreneur
1 month ago

This Former Hockey Player Is Betting Glucose Monitoring Will Change How People Think About Their Weight

Signos created the first FDA-cleared glucose monitoring platform for weight management, combining CGM and AI to help people understand and manage their metabolism.
fromwww.bbc.com
2 months ago

'Weight-loss jab helped me find my cancer'

The cancer was fastacting, and if I'd left it even six months, the outcome could have been much worse,
Medicine
Medicine
fromwww.theguardian.com
2 months ago

People are turning themselves into lab rats': the injectable peptides craze sweeping the US

Grey-market injectable peptides are unapproved, widely used by biohackers despite lacking reliable safety data, quality control, and presenting potential health and legal risks.
fromwww.bbc.com
1 month ago

Stroke survivors trial new at-home tech: 'It's given me my freedom back'

"I heard a pop in my head, like a big bubble," she said. "I tried to scream, but it wasn't a normal scream. I knew something wasn't right."
Medicine
[ Load more ]